Key principles for the improved conduct of health technology assessments for resource allocation decisions
Top Cited Papers
- 4 July 2008
- journal article
- general essays
- Published by Cambridge University Press (CUP) in International Journal of Technology Assessment in Health Care
- Vol. 24 (03) , 244-258
- https://doi.org/10.1017/s0266462308080343
Abstract
Health technology assessment (HTA) is a dynamic, rapidly evolving process, embracing different types of assessments that inform real-world decisions about the value (i.e., benefits, risks, and costs) of new and existing technologies. Historically, most HTA agencies have focused on producing high quality assessment reports that can be used by a range of decision makers. However, increasingly organizations are undertaking or commissioning HTAs to inform a particular resource allocation decision, such as listing a drug on a national or local formulary, defining the range of coverage under insurance plans, or issuing mandatory guidance on the use of health technologies in a particular healthcare system. A set of fifteen principles that can be used in assessing existing or establishing new HTA activities is proposed, providing examples from existing HTA programs. The principal focus is on those HTA activities that are linked to, or include, a particular resource allocation decision. In these HTAs, the consideration of both costs and benefits, in an economic evaluation, is critical. It is also important to consider the link between the HTA and the decision that will follow. The principles are organized into four sections: (i) “Structure” of HTA programs; (ii) “Methods” of HTA; (iii) “Processes for Conduct” of HTA; and (iv) “Use of HTAs in Decision Making.”Keywords
This publication has 30 references indexed in Scilit:
- Priority setting for health technology assessments: A systematic review of current practical approachesInternational Journal of Technology Assessment in Health Care, 2007
- Probabilistic Analysis and Computationally Expensive Models: Necessary and Required?Value in Health, 2006
- Building Bridges Between Academic Research and Policy FormulationPharmacoEconomics, 2006
- What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviewsBMJ, 2004
- National Institute for Clinical Excellence and its value judgmentsBMJ, 2004
- When should decision-analytic modeling be used in the economic evaluation of health care?The European Journal of Health Economics, 2003
- Cost-Effectiveness Analysis and the Consistency of Decision MakingPharmacoEconomics, 2001
- Evidence based medicine: what it is and what it isn'tBMJ, 1996
- Support for trials of promising medications through the Pharmaceutical Benefits SchemeThe Medical Journal of Australia, 1995
- Criteria for Standard Versus Experimental TherapyHealth Affairs, 1994